Tenet Reports Results for the Third Quarter Ended September 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Tenet Healthcare (THC) Tops Q3 EPS by 23c; Lower Outlook
November 6, 2017 4:23 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of ($0.17), $0.23 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $4.59 billion versus the consensus estimate of $4.68 billion.
GUIDANCE:
Tenet Healthcare sees FY2017 EPS of $0.59-$0.74, versus the consensus of $0.76.
Reported a net loss from continuing operations attributable to Tenet shareholders of $366 million or $3.63 per diluted share. Adjusted diluted loss per share from continuing operations was $0.17.Adjusted EBITDA was $507 million... More